Showing results (51-60 of 233) with videos related to
Sort By:
Pageof 24
Frontiers in Pediatrics|September 5, 2024
Caplacizumab as an add-on therapy in a 7-year-old girl with exacerbated immune-mediated thrombotic thrombocytopenic purpura, a case report and literature reviewLara Chavaz, Laurent Cimasoni, Johanna A Kremer Hovinga, et al.Clinical Case Reports|August 8, 2017
Acute pancreatitis in immunocompromised patients: beware of varicella zoster virus primo-infectionAdrien Picod, Elise Corre, Eric Maury, et al.Hamostaseologie|February 19, 2021
Thrombotic Thrombocytopenic Purpura: When Basic Science Meets Clinical ResearchGaëlle Bécel, Sylvia Faict, Adrien Picod, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 17, 2022
Hemophagocytic Lymphohistiocytosis Associated With Cytomegalovirus Infection: 5 Cases and a Systematic Review of the LiteratureKevin Chevalier, Julien Schmidt, Paul Coppo, et al.Haematologica|September 26, 2024
Acquired thrombotic thrombocytopenic purpura without detectable anti-ADAMTS13 antibodies: a possible underlying autoimmune mechanismDelphine Simon, Mathilde Leclercq, Bérangère Joly, et al.Arthritis and Rheumatism|April 29, 2008
Low glycosylated ferritin, a good marker for the diagnosis of hemophagocytic syndromeLaurence Fardet, Paul Coppo, Adrien Kettaneh, et al.Journal of Thrombosis and Haemostasis : JTH|November 5, 2025
Successful use of recombinant ADAMTS13 in a pregnant patient with immune-mediated thrombotic thrombocytopenic purpuraRaphael Cauchois, Pascale Poullin, Alexandre Hertig, et al.Nephrologie & Therapeutique|February 8, 2021
[ESUR recommendations on the use of contrast media: Practice survey, review and commentary by CJN, FIRN and SFNDT]Louis de Laforcade, Mickaël Bobot, Marie-France Bellin, et al.Clinical Kidney Journal|December 15, 2025
One tool, multiple gains: anti-CD38 therapy in antibody-mediated rejectionRaphaël Etiève, Margaux Van Wynsberghe, Steven Grangé, et al.Journal of Autoimmunity|February 10, 2015
The diffuse infiltrative lymphocytosis syndrome (DILS). A comprehensive reviewEtienne Ghrenassia, Nihal Martis, Julien Boyer, et al.Pageof 24